Trial NCT01953926

View at ClinicalTrials.gov 
Org. Study IDs: PUMA-NER-5201
Secondary IDs: 2013-002872-42

Last trial update was posted on 2024-03-12

MeSH Interventions

Fulvestrant Neratinib Paclitaxel Trastuzumab

MeSH Conditions

Neoplasms

Other Conditions

Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

Stopping Reasons

The study was terminated to align with the sponsor's current development plans for neratinib. The decision was not based on any new efficacy or safety data for neratinib.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID